Helicobacter and Salmonella persistent infection strategies

Cold Spring Harbor Perspectives in Medicine

Volumn 3, Issue 12, 2013, Pages

  Monack, Denise M ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL SURVIVAL; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CHEMOTAXIS; CHOLECYSTITIS; COLONY FORMATION; HELICOBACTER INFECTION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOMODULATION; INFECTION CONTROL; INNATE IMMUNITY; INTESTINE FLORA; MICROBIAL COLONIZATION; MICROBIAL COMMUNITY; NONHUMAN; REGULATORY T LYMPHOCYTE; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; ANIMAL; CELL MOTION; CHRONIC DISEASE; DISEASE TRANSMISSION; GASTROINTESTINAL TRACT; HELICOBACTER PYLORI; IMMUNE EVASION; IMMUNOLOGY; MICROBIOLOGY; MOUSE; PHYSIOLOGY; REVIEW; STOMACH DISEASE; STOMACH MUCOSA;

ANIMALS; CELL MOVEMENT; CHRONIC DISEASE; GASTRIC MUCOSA; GASTROINTESTINAL TRACT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; MICE; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; STOMACH DISEASES; T-LYMPHOCYTES, REGULATORY;

EID: 84889035308     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a010348     Document Type: Article

References (164)

1. Alegado RA, Tan MW. 2008. Resistance to antimicrobial peptides contributes to persistence of Salmonella typhimurium in the C. elegans intestine. Cell Microbiol 10: 1259-1273.
2. Amieva MR, El-Omar EM. 2008. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterology 134: 306-323.
3. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. 2003. Disruption of the epithelial apicaljunctional complex by Helicobacter pylori CagA. Science 300: 1430-1434.
4. Andersen-Nissen E, Smith KD, Strobe KL, Barrett SL, Cookson BT, Logan SM, Aderem A. 2005. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci 102: 9247-9252.
5. Asahi M, Azuma T, Ito S, Ito Y, Suto H, Nagai Y, Tsubokawa M, Tohyama Y, Maeda S, Omata M, et al. 2000. Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells. J Exp Med 191: 593-602.
6. Backert S, Clyne M. 2011. Pathogenesis of Helicobacter pylori infection. Helicobacter 16: 19-25.
7. Backert S, Ziska E, Brinkmann V, Zimny-Arndt U, Fauconnier A, Jungblut PR, Naumann M, Meyer TF. 2000. Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus. Cell Microbiol 2: 155-164.
8. Backert S, Tegtmeyer N, Selbach M. 2010. The versatility of Helicobacter pylori CagA effector protein functions: The master key hypothesis. Helicobacter 15: 163-176.
9. Backert S, Clyne M, Tegtmeyer N. 2011. Molecular mechanisms of gastric epithelial cell adhesion and injection of CagA by Helicobacter pylori. Cell Commun Signal 9: 28.
10. Bader MW, Sanowar S, Daley ME, Schneider AR, Cho U, Xu W, Klevit RE, Le Moual H, Miller SI. 2005. Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 122: 461-472.
11. Bagnoli F, Buti L, Tompkins L, Covacci A, Amieva MR. 2005. Helicobacter pylori CagA induces a transition from polarized to invasive phenotypes in MDCK cells. Proc Natl Acad Sci 102: 16339-16344.
12. Baker S, Dougan G. 2007. The genome of Salmonella enterica serovar Typhi. Clin Infect Dis 45: S29-S33.
13. Bardhan PK. 1997. Epidemiological features of Helicobacter pylori infection in developing countries. Clin Infect Dis 25: 973-978.
14. Barman M, Unold D, Shifley K, Amir E, Hung K, Bos N, Salzman N. 2008. Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract. Infect Immun 76: 907-915.
15. Bauer-Garland J, Frye JG, Gray JT, Berrang ME, Harrison MA, Fedorka-Cray PJ. 2006. Transmission of Salmonella enterica serotype Typhimurium in poultry with and without antimicrobial selective pressure. J Appl Microbiol 101: 1301-1308.
16. Bäumler A, Fang FC. 2013. Host specificity of bacterial pathogens. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a010041.
17. Bearson BL, Wilson L, Foster JW. 1998. A low pH-inducible, PhoPQ-dependent acid tolerance response protects Salmonella typhimurium against inorganic acid stress. J Bacteriol 180: 2409-2417.
18. Bolam DN, Sonnenburg JL. 2011. Mechanistic insight into polysaccharide use within the intestinal microbiota. Gut Microbes 2: 86-90.
19. Brodsky IE, Ghori N, Falkow S, Monack D. 2005. Mig-14 is an inner membrane-associated protein that promotes Salmonella typhimurium resistance to CRAMP, survival within activated macrophages and persistent infection. Mol Microbiol 55: 954-972.
20. Brown LM. 2000. Helicobacter pylori: Epidemiology and routes of transmission. Epidemiol Rev 22: 283-297.
21. Cash HL, Whitham CV, Behrendt CL, Hooper LV. 2006. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313: 1126-1130.
22. Cheminay C, Mohlenbrink A, Hensel M. 2005. Intracellular Salmonella inhibit antigen presentation by dendritic cells. J Immunol 174: 2892-2899.
23. Cirillo DM, Valdivia RH, Monack DM, Falkow S. 1998. Macrophage-dependent induction of the Salmonella pathogenicity island 2 type III secretion system and its role in intracellular survival. Mol Microbiol 30: 175-188.
24. Crawford RW, Gibson DL, Kay WW, Gunn JS. 2008. Identification of a bile-induced exopolysaccharide required for Salmonella biofilm formation on gallstone surfaces. Infect Immun 76: 5341-5349.
25. Crawford RW, Rosales-Reyes R, Ramirez-Aguilar Mde L, Chapa-Azuela O, Alpuche-Aranda C, Gunn JS. 2010. Gallstones play a significant role in Salmonella spp. gallbladder colonization and carriage. Proc Natl Acad Sci 107: 4353-4358.
26. Croxen MA, Sisson G, Melano R, Hoffman PS. 2006. The Helicobacter pylori chemotaxis receptor TlpB (HP0103) is required for pH taxis and for colonization of the gastric mucosa. J Bacteriol 188: 2656-2665.
27. Deiwick J, Nikolaus T, Shea JE, Gleeson C, Holden DW, Hensel M. 1998. Mutations in Salmonella pathogenicity island 2 (SPI2) genes affecting transcription of SPI1 genes and resistance to antimicrobial agents. J Bacteriol 180: 4775-4780.
28. Detweiler CS, Monack DM, Brodsky IE, Mathew H, Falkow S. 2003. virK, somA and rcsC are important for systemic Salmonella enterica serovar Typhimurium infection and cationic peptide resistance. Mol Microbiol 48: 385-400.
29. Dhanoa A, Fatt QK. 2009. Non-typhoidal Salmonella bacteraemia: Epidemiology, clinical characteristics and its association with severe immunosuppression. Ann Clin Microbiol Antimicrob 8: 15.
30. Dinbar A, Altmann G, Tulcinsky DB. 1969. The treatment of chronic biliary salmonella carriers. Am J Med 47: 236-242.
31. Dorsey CW, Laarakker MC, Humphries AD, Weening EH, Bäumler AJ. 2005. Salmonella enterica serotype Typhimurium MisL is an intestinal colonization factor that binds fibronectin. Mol Microbiol 57: 196-211.
32. Dougan G, John V, Palmer S, Mastroeni P. 2011. Immunity to salmonellosis. Immunol Rev 240: 196-210.
33. Ebert D, Bull JJ. 2003. Challenging the trade-off model for the evolution of virulence: Is virulence management feasible? Trends Microbiol 11: 15-20.
34. Endt K, Stecher B, Chaffron S, Slack E, Tchitchek N, Benecke A, Van Maele L, Sirard JC, Mueller AJ, Heikenwalder M, et al. 2010. The microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrhea. PLoS Pathog 6: e1001097.
35. Erickson KD, Detweiler CS. 2006. The Rcs phosphorelay system is specific to enteric pathogens/commensals and activates ydeI, a gene important for persistent Salmonella infection of mice. Mol Microbiol 62: 883-894.
36. Falush D, Wirth T, Linz B, Pritchard JK, Stephens M, Kidd M, Blaser MJ, Graham DY, Vacher S, Perez-Perez GI, et al. 2003. Traces of human migrations in Helicobacter pylori populations. Science 299: 1582-1585.
37. Foster JW. 1995. Low pH adaptation and the acid tolerance response of Salmonella typhimurium. Crit Rev Microbiol 21: 215-237.
38. Galan JE. 2001. Salmonella interactions with host cells: Type III secretion at work. Annu Rev Cell Dev Biol 17: 53-86.
39. Gal-Mor O, Gibson DL, Baluta D, Vallance BA, Finlay BB. 2008. A novel secretion pathway of Salmonella enterica acts as an antivirulence modulator during salmonellosis. PLoS Pathog 4: e1000036.
40. Gewirtz AT, Yu Y, Krishna US, Israel DA, Lyons SL, Peek RM Jr. 2004. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. J Infect Dis 189: 1914-1920.
41. Glynn MK, Reddy V, Hutwagner L, Rabatsky-Ehr T, Shiferaw B, Vugia DJ, Segler S, Bender J, Barrett TJ, Angulo FJ. 2004. Prior antimicrobial agent use increases the risk of sporadic infections with multidrug-resistant Salmonella enterica serotype Typhimurium: A FoodNet case-control study, 1996-1997. Clin Infect Dis 38: S227-S236.
42. Gonzalez-Escobedo G, Marshall JM, Gunn JS. 2011. Chronic and acute infection of the gall bladder by Salmonella Typhi: Understanding the carrier state. Nat Rev Microbiol 9: 9-14.
43. Gordon MA, Graham SM, Walsh AL, Wilson L, Phiri A, Molyneux E, Zijlstra EE, Heyderman RS, Hart CA, Molyneux ME. 2008. Epidemics of invasive Salmonella enterica serovar enteritidis and S. enterica serovar Typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin Infect Dis 46: 963-969.
44. Govoni G, Vidal S, Cellier M, Lepage P, Malo D, Gros P. 1995. Genomic structure, promoter sequence, and induction of expression of the mouse Nramp1 gene in macrophages. Genomics 27: 9-19.
45. {thorn} environments. J Bacteriol 179: 7040-7045.
46. Guina T, Yi EC, Wang H, Hackett M, Miller SI. 2000. A PhoP-regulated outer membrane protease of Salmonella enterica serovar Typhimurium promotes resistance to ahelical antimicrobial peptides. J Bacteriol 182: 4077-4086.
47. Halici S, Zenk SF, Jantsch J, Hensel M. 2008. Functional analysis of the Salmonella pathogenicity island 2-mediated inhibition of antigen presentation in dendritic cells. Infect Immun 76: 4924-4933.
48. Hall-Stoodley L, Stoodley P. 2009. Evolving concepts in biofilm infections. Cell Microbiol 11: 1034-1043.
49. Handa O, Naito Y, Yoshikawa T. 2007. CagA protein of Helicobacter pylori: A hijacker of gastric epithelial cell signaling. Biochem Pharmacol 73: 1697-1702.
50. Haraga A, Ohlson MB, Miller SI. 2008. Salmonellae interplay with host cells. Nat Rev Microbiol 6: 53-66.
51. Hatakeyama M. 2004. Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 4: 688-694.
52. Hatakeyama M. 2008. Linking epithelial polarity and carcinogenesis by multitasking Helicobacter pylori virulence factor CagA. Oncogene 27: 7047-7054.
53. Helaine S, Thompson JA, Watson KG, Liu M, Boyle C, Holden DW. 2010. Dynamics of intracellular bacterial replication at the single cell level. Proc Natl Acad Sci 107: 3746-3751.
54. Hensel M, Shea JE, Waterman SR, Mundy R, Nikolaus T, Banks G, Vazquez-Torres A, Gleeson C, Fang FC, Holden DW. 1998. Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol Microbiol 30: 163-174.
55. Hesse M, Piccirillo CA, Belkaid Y, Prufer J, Mentink-Kane M, Leusink M, Cheever AW, Shevach EM, Wynn TA. 2004. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J Immunol 172: 3157-3166.
56. Hessey SJ, Spencer J, Wyatt JI, Sobala G, Rathbone BJ, Axon AT, Dixon MF. 1990. Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut 31: 134-138.
57. {thorn} regulatory T cells. Nat Med 10: 29-30.
58. Hormaeche CE. 1979. Natural resistance to Salmonella typhimurium in different inbred mouse strains. Immunology 37: 311-318.
59. Howitt MR, Lee JY, Lertsethtakarn P, Vogelmann R, Joubert LM, Ottemann KM, Amieva MR. 2011. ChePep controls Helicobacter pylori infection of the gastric glands and chemotaxis in the Epsilonproteobacteria. MBio 2: e00098-11.
60. Humphries AD, Townsend SM, Kingsley RA, Nicholson TL, Tsolis RM, Bäumler AJ. 2001. Role of fimbriae as antigens and intestinal colonization factors of Salmonella serovars. FEMS Microbiol Lett 201: 121-125.
61. Hunt RH. 1996. The role of Helicobacter pylori in pathogenesis: The spectrum of clinical outcomes. Scand J Gastroenterol Suppl 220: 3-9.
62. Ibarra JA, Steele-Mortimer O. 2009. Salmonella-The ultimate insider. Salmonella virulence factors that modulate intracellular survival. Cell Microbiol 11: 1579-1586.
63. Ilver D, Arnqvist A, Ogren J, Frick IM, Kersulyte D, Incecik ET, Berg DE, Covacci A, Engstrand L, Boren T. 1998. Helicobacter pylori adhesin binding fucosylated histoblood group antigens revealed by retagging. Science 279: 373-377.
64. Johanns TM, Ertelt JM, Rowe JH, Way SS. 2010. Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathog 6: e1001043.
65. Jones BD, Falkow S. 1996. Salmonellosis: Host immune responses and bacterial virulence determinants. Annu Rev Immunol 14: 533-561.
66. Jones BD, Ghori N, Falkow S. 1994. Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches. J Exp Med 180: 15-23.
67. Kariuki S, Revathi G, Kariuki N, Kiiru J, Mwituria J, Muyodi J, Githinji JW, Kagendo D, Munyalo A, Hart CA. 2006. Invasive multidrug-resistant non-typhoidal Salmonella infections in Africa: Zoonotic or anthroponotic transmission? J Med Microbiol 55: 585-591.
68. Kingsley RA, van Amsterdam K, Kramer N, Bäumler AJ. 2000. The shdA gene is restricted to serotypes of Salmonella enterica subspecies I and contributes to efficient and prolonged fecal shedding. Infect Immun 68: 2720-2727.
69. Kingsley RA, Santos RL, Keestra AM, Adams LG, Bäumler AJ. 2002a. Salmonella enterica serotype Typhimurium ShdA is an outer membrane fibronectin-binding protein that is expressed in the intestine. Mol Microbiol 43: 895-905.
70. Kingsley RA, Weening EH, Keestra AM, Bäumler AJ. 2002b. Population heterogeneity of Salmonella enterica serotype Typhimurium resulting from phase variation of the lpf operon in vitro and in vivo. J Bacteriol 184: 2352-2359.
71. Kingsley RA, Abi Ghanem D, Puebla-Osorio N, Keestra AM, Berghman L, Bäumler AJ. 2004. Fibronectin binding to the Salmonella enterica serotype Typhimurium ShdA autotransporter protein is inhibited by a monoclonal antibody recognizing the A3 repeat. J Bacteriol 186: 4931-4939.
72. Kivi M, Johansson AL, Reilly M, Tindberg Y. 2005. Helicobacter pylori status in family members as risk factors for infection in children. Epidemiol Infect 133: 645-652.
73. Knodler LA, Vallance BA, Celli J, Winfree S, Hansen B, Montero M, Steele-Mortimer O. 2010. Dissemination of invasive Salmonella via bacterial-induced extrusion of mucosal epithelia. Proc Natl Acad Sci 107: 17733-17738.
74. Kohbata S, Yokoyama H, Yabuuchi E. 1986. Cytopathogenic effect of Salmonella typhi GIFU 10007 on M cells of murine ileal Peyer's patches in ligated ileal loops: An ultrastructural study. Microbiol Immunol 30: 1225-1237.
75. Lawley TD, Chan K, Thompson LJ, Kim CC, Govoni GR, Monack DM. 2006. Genome-wide screen for Salmonella genes required for long-term systemic infection of the mouse. PLoS Pathog 2: e11.
76. Lawley TD, Bouley DM, Hoy YE, Gerke C, Relman DA, Monack DM. 2008. Host transmission of Salmonella enterica serovar Typhimurium is controlled by virulence factors and indigenous intestinal microbiota. Infect Immun 76: 403-416.
77. Lee IS, Lin J, Hall HK, Bearson B, Foster JW. 1995. The stationary-phase sigma factor sigma S (RpoS) is required for a sustained acid tolerance response in virulent Salmonella typhimurium. Mol Microbiol 17: 155-167.
78. Lertsethtakarn P, Ottemann KM, Hendrixson DR. 2011. Motility and chemotaxis in Campylobacter and Helicobacter. Annu Rev Microbiol 65: 389-410.
79. Levine MM, Black RE, Lanata C. 1982. Precise estimation of the numbers of chronic carriers of Salmonella typhi in Santiago, Chile, an endemic area. J Infect Dis 146: 724-726.
80. Lin J, Lee IS, Frey J, Slonczewski JL, Foster JW. 1995. Comparative analysis of extreme acid survival in Salmonella typhimurium, Shigella flexneri, and Escherichia coli. J Bacteriol 177: 4097-4104.
81. Linz B, Balloux F, Moodley Y, Manica A, Liu H, Roumagnac P, Falush D, Stamer C, Prugnolle F, van der Merwe SW, et al. 2007. An African origin for the intimate association between humans and Helicobacter pylori. Nature 445: 915-918.
82. Lipsitch M, Moxon ER. 1997. Virulence and transmissibility of pathogens: What is the relationship? Trends Microbiol 5: 31-37.
83. {thorn} T cells on Plasmodium berghei NK65 infection in BALB/c mice. Int J Parasitol 33: 175-183.
84. Mahdavi J, Sonden B, Hurtig M, Olfat FO, Forsberg L, Roche N, Angstrom J, Larsson T, Teneberg S, Karlsson KA, et al. 2002. Helicobacter pylori SabA adhesin in persistent infection and chronic inflammation. Science 297: 573-578.
85. Mastroeni P, Grant AJ. 2011. Spread of Salmonella enterica in the body during systemic infection: Unravelling host and pathogen determinants. Expert Rev Mol Med 13: e12.
86. Mastroeni P, Menager N. 2003. Development of acquired immunity to Salmonella. J Med Microbiol 52: 453-459.
87. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122: 107-118.
88. McCallion WA, Murray LJ, Bailie AG, Dalzell AM, O'Reilly DP, Bamford KB. 1996. Helicobacter pylori infection in children: Relation with current household living conditions. Gut 39: 18-21.
89. McGhie EJ, Brawn LC, Hume PJ, Humphreys D, Koronakis V. 2009. Salmonella takes control: Effector-driven manipulation of the host. Curr Opin Microbiol 12: 117-124.
90. McLaughlin LM, Govoni GR, Gerke C, Gopinath S, Peng K, Laidlaw G, Chien YH, Jeong HW, Li Z, Brown MD, et al. 2009. The Salmonella SPI2 effector SseI mediates longterm systemic infection by modulating host cell migration. PLoS Pathog 5: e1000671.
91. Mecsas J, Bilis I, Falkow S. 2001. Identification of attenuated Yersinia pseudotuberculosis strains and characterization of an orogastric infection in BALB/c mice on day 5 postinfection by signature-tagged mutagenesis. Infect Immun 69: 2779-2787.
92. {thorn} regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med 200: 201-210.
93. Merrell DS, Butler SM, Qadri F, Dolganov NA, Alam A, Cohen MB, Calderwood SB, Schoolnik GK, Camilli A. 2002. Host-induced epidemic spread of the cholera bacterium. Nature 417: 642-645.
94. Merrell DS, Goodrich ML, Otto G, Tompkins LS, Falkow S. 2003. pH-regulated gene expression of the gastric pathogen Helicobacter pylori. Infect Immun 71: 3529-3539.
95. Meynell GG. 1957. The applicability of the hypothesis of independent action to fatal infections in mice given Salmonella typhimurium by mouth. J Gen Microbiol 16: 396-404.
96. Meynell GG, Stocker BA. 1957. Some hypotheses on the aetiology of fatal infections in partially resistant hosts and their application to mice challenged with Salmonella paratyphi-B or Salmonella typhimurium by intraperitoneal injection. J Gen Microbiol 16: 38-58.
97. Miao EA, Miller SI. 2000. A conserved amino acid sequence directing intracellular type III secretion by Salmonella typhimurium. Proc Natl Acad Sci 97: 7539-7544.
98. Mittrucker HW, Raupach B, Kohler A, Kaufmann SH. 2000. Cutting edge: Role of B lymphocytes in protective immunity against Salmonella typhimurium infection. J Immunol 164: 1648-1652.
99. {thorn}/ {thorn} mice and can be reactivated by IFN-g neutralization. J Exp Med 199: 231-241.
100. Monack DM, Mueller A, Falkow S. 2004b. Persistent bacterial infections: The interface of the pathogen and the host immune system. Nat Rev Microbiol 2: 747-765.
101. Moran AP. 2007. Lipopolysaccharide in bacterial chronic infection: Insights from Helicobacter pylori lipopolysaccharide and lipid A. Int J Med Microbiol 297: 307-319.
102. Moran AP. 2008. Relevance of fucosylation and Lewis antigen expression in the bacterial gastroduodenal pathogen Helicobacter pylori. Carbohydr Res 343: 1952-1965.
103. Murata-Kamiya N. 2011. Pathophysiological functions of the CagA oncoprotein during infection by Helicobacter pylori. Microbes Infect 13: 799-807.
104. Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, Aburatani H, Akiyama T, Peek RM Jr, Azuma T, et al. 2007. Helicobacter pylori CagA interacts with E-cadherin and deregulates the b-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene 26: 4617-4626.
105. Nix RN, Altschuler SE, Henson PM, Detweiler CS. 2007. Hemophagocytic macrophages harbor Salmonella enterica during persistent infection. PLoS Pathog 3: e193.
106. Odenbreit S, Puls J, Sedlmaier B, Gerland E, Fischer W, Haas R. 2000. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287: 1497-1500.
107. Ottemann KM, Lowenthal AC. 2002. Helicobacter pylori uses motility for initial colonization and to attain robust infection. Infect Immun 70: 1984-1990.
108. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. 2002. Typhoid fever. N Engl J Med 347: 1770-1782.
109. Peek RM Jr. 2005. Orchestration of aberrant epithelial signaling by Helicobacter pylori CagA. Sci STKE 2005: pe14
110. Qiao XT, Ziel JW, McKimpson W, Madison BB, Todisco A, Merchant JL, Samuelson LC, Gumucio DL. 2007. Prospective identification of a multilineage progenitor in murine stomach epithelium. Gastroenterology 133: 1989-1998.
111. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. 2004. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
112. Retamal P, Castillo-Ruiz M, Villagra NA, Morgado J, Mora GC. 2010. Modified intracellular-associated phenotypes in a recombinant Salmonella Typhi expressing S. Typhimurium SPI-3 sequences. PloS ONE 5: e9394.
113. Riley LW, Cohen ML, Seals JE, Blaser MJ, Birkness KA, Hargrett NT, Martin SM, Feldman RA. 1984. Importance of host factors in human salmonellosis caused by multiresistant strains of Salmonella. J Infect Dis 149: 878-883.
114. Saadat I, Higashi H, Obuse C, Umeda M, Murata-Kamiya N, Saito Y, Lu H, Ohnishi N, Azuma T, Suzuki A, et al. 2007. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 447: 330-333.
115. Sabbagh SC, Forest CG, Lepage C, Leclerc JM, Daigle F. 2010. So similar, yet so different: Uncovering distinctive features in the genomes of Salmonella enterica serovars Typhimurium and Typhi. FEMS Microbiol Lett 305: 1-13.
116. Salzman NH. 2011. Microbiota-immune system interaction: An uneasy alliance. Curr Opin Microbiol 14: 99-105.
117. Scher K, Romling U, Yaron S. 2005. Effect of heat, acidification, and chlorination on Salmonella enterica serovar typhimurium cells in a biofilm formed at the air-liquid interface. Appl Environ Microbiol 71: 1163-1168.
118. Schreiber S, Konradt M, Groll C, Scheid P, Hanauer G, Werling HO, Josenhans C, Suerbaum S. 2004. The spatial orientation of Helicobacter pylori in the gastric mucus. Proc Natl Acad Sci 101: 5024-5029.
119. Schreiber S, Bucker R, Groll C, Azevedo-Vethacke M, Garten D, Scheid P, Friedrich S, Gatermann S, Josenhans C, Suerbaum S. 2005. Rapid loss of motility of Helicobacter pylori in the gastric lumen in vivo. Infect Immun 73: 1584-1589.
120. Segal ED, Cha J, Lo J, Falkow S, Tompkins LS. 1999. Altered states: Involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori. Proc Natl Acad Sci 96: 14559-14564.
121. Sekirov I, Russell SL, Antunes LC, Finlay BB. 2010. Gut microbiota in health and disease. Physiol Rev 90: 859-904.
122. Sigauque B, Roca A, Mandomando I, Morais L, Quinto L, Sacarlal J, Macete E, Nhamposa T, Machevo S, Aide P, et al. 2009. Community-acquired bacteremia among children admitted to a rural hospital in Mozambique. Pediatr Infect Dis J 28: 108-113.
123. Song J, Gao X, Galan JE. 2013. Structure and function of the Salmonella Typhi chimaeric A2B5 typhoid toxin. Nature 499: 350-354.
124. Sonnenburg JL, Chen CT, Gordon JI. 2006. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol 4: e413.
125. Sonnenburg ED, Zheng H, Joglekar P, Higginbottom SK, Firbank SJ, Bolam DN, Sonnenburg JL. 2010. Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell 141: 1241-1252.
126. Spano S, Galan JE. 2012. A Rab32-dependent pathway contributes to Salmonella Typhi host restriction. Science 338: 960-963.
127. Spector MP. 1998. The starvation-stress response (SSR) of Salmonella. Adv Microb Physiol 40: 233-279.
128. Stecher B, Hardt WD. 2011. Mechanisms controlling pathogen colonization of the gut. Curr Opin Microbiol 14: 82-91.
129. Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, Kremer M, Chaffron S, Macpherson AJ, Buer J, Parkhill J, et al. 2007. Salmonella enterica serovar Typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 5: 2177-2189.
130. Steer HW. 1984. Surface morphology of the gastroduodenal mucosa in duodenal ulceration. Gut 25: 1203-1210.
131. Stein M, Rappuoli R, Covacci A. 2000. Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cagdriven host cell translocation. Proc Natl Acad Sci 97: 1263-1268.
132. {thorn} T cell responses. J Exp Med 198: 889-901.
133. {thorn} regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol 172: 4123-4132.
134. Suzuki T, Matsuo K, Sawaki A, Ito H, Hirose K, Wakai K, Sato S, Nakamura T, Yamao K, Ueda R, et al. 2006. Systematic review and meta-analysis: Importance of CagA status for successful eradication of Helicobacter pylori infection. Aliment Pharmacol Ther 24: 273-280.
135. Tan S, Tompkins LS, Amieva MR. 2009. Helicobacter pylori usurps cell polarity to turn the cell surface into a replicative niche. PLoS Pathog 5: e1000407.
136. Tan S, Noto JM, Romero-Gallo J, Peek RM Jr, Amieva MR. 2011. Helicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface. PLoS Pathog 7: e1002050.
137. Tegtmeyer N, Wessler S, Backert S. 2011. Role of the cagpathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J 278: 1190-1202.
138. Terry K, Williams SM, Connolly L, Ottemann KM. 2005. Chemotaxis plays multiple roles during Helicobacter pylori animal infection. Infect Immun 73: 803-811.
139. Thompson LJ, Dunstan SJ, Dolecek C, Perkins T, House D, Dougan G, Nguyen TH, Tran TP, Doan CD, Le TP, et al. 2009. Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi. Proc Natl Acad Sci 106: 22433-22438.
140. Tobar JA, Carreno LJ, Bueno SM, Gonzalez PA, Mora JE, Quezada SA, Kalergis AM. 2006. Virulent Salmonella enterica serovar Typhimurium evades adaptive immunity by preventing dendritic cells from activating T cells. Infect Immun 74: 6438-6448.
141. Tran QT, Gomez G, Khare S, Lawhon SD, Raffatellu M, Bäumler AJ, Ajithdoss D, Dhavala S, Adams LG. 2010. The Salmonella enterica serotype Typhi Vi capsular antigen is expressed after the bacterium enters the ileal mucosa. Infect Immun 78: 527-535.
142. Trombert AN, Rodas PI, Mora GC. 2011. Reduced invasion to human epithelial cell lines of Salmonella enterica serovar Typhi carrying S. Typhimurium sopD2. FEMS Microbiol Lett 322: 150-156.
143. Tsolis RM, Young GM, Solnick JV, Bäumler AJ. 2008. From bench to bedside: Stealth of enteroinvasive pathogens. Nat Rev Microbiol 6: 883-892.
144. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. 2001. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345: 784-789.
145. Uzonna JE, Wei G, Yurkowski D, Bretscher P. 2001. Immune elimination of Leishmania major in mice: Implications for immune memory, vaccination, and reactivation disease. J Immunol 167: 6967-6974.
146. Valdez Y, Ferreira RB, Finlay BB. 2009. Molecular mechanisms of Salmonella virulence and host resistance. Curr Top Microbiol Immunol 337: 93-127.
147. Vazquez-Torres A, Jones-Carson J, Bäumler AJ, Falkow S, Valdivia R, Brown W, Le M, Berggren R, Parks WT, Fang FC. 1999. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401: 804-808.
148. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. 1993. Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg. Cell 73: 469-485.
149. Vogelsang TM, Boe J. 1948. Temporary and chronic carriers of Salmonella Typhi and Salmonella Paratyphi B. J Hyg (Lond) 46: 252-261.
150. Wagner C, Hensel M. 2011. Adhesive mechanisms of Salmonella enterica. Adv Exp Med Biol 715: 17-34.
151. Weening EH, Barker JD, Laarakker MC, Humphries AD, Tsolis RM, Bäumler AJ. 2005. The Salmonella enterica serotype Typhimurium lpf, bcf, stb, stc, std, and sth fimbrial operons are required for intestinal persistence in mice. Infect Immun 73: 3358-3366.
152. Weyermann M, Adler G, Brenner H, Rothenbacher D. 2006. The mother as source of Helicobacter pylori infection. Epidemiology 17: 332-334.
153. White AP, Gibson DL, Kim W, Kay WW, Surette MG. 2006. Thin aggregative fimbriae and cellulose enhance longterm survival and persistence of Salmonella. J Bacteriol 188: 3219-3227.
154. White AP, Gibson DL, Grassl GA, Kay WW, Finlay BB, Vallance BA, Surette MG. 2008. Aggregation via the red, dry, and rough morphotype is not a virulence adaptation in Salmonella enterica serovar Typhimurium. Infect Immun 76: 1048-1058.
155. Wijburg OL, Uren TK, Simpfendorfer K, Johansen FE, Brandtzaeg P, Strugnell RA. 2006. Innate secretory antibodies protect against natural Salmonella Typhimurium infection. J Exp Med 203: 21-26.
156. Williams SM, Chen YT, Andermann TM, Carter JE, McGee DJ, Ottemann KM. 2007. Helicobacter pylori chemotaxis modulates inflammation and bacterium-gastric epithelium interactions in infected mice. Infect Immun 75: 3747-3757.
157. Wilson RP, Raffatellu M, Chessa D, Winter SE, Tukel C, Bäumler AJ. 2008. The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella. Cell Microbiol 10: 876-890.
158. Winter SE, Raffatellu M, Wilson RP, Russmann H, Bäumler AJ. 2008. The Salmonella enterica serotype Typhi regulator TviA reduces interleukin-8 production in intestinal epithelial cells by repressing flagellin secretion. Cell Microbiol 10: 247-261.
159. Winter SE, Winter MG, Thiennimitr P, Gerriets VA, Nuccio SP, Russmann H, Bäumler AJ. 2009. The TviA auxiliary protein renders the Salmonella enterica serotype Typhi RcsB regulon responsive to changes in osmolarity. Mol Microbiol 74: 175-193.
160. Winter SE, Thiennimitr P, Winter MG, Butler BP, Huseby DL, Crawford RW, Russell JM, Bevins CL, Adams LG, Tsolis RM, et al. 2010. Gut inflammation provides a respiratory electron acceptor for Salmonella. Nature 467: 426-429.
161. Yen YF, Wang FD, Chiou CS, Chen YY, Lin ML, Chen TL, Liu CY. 2009. Prognostic factors and clinical features of nontyphoid Salmonella bacteremia in adults. J Chin Med Assoc 72: 408-413.
162. Young D, Hussell T, Dougan G. 2002. Chronic bacterial infections: Living with unwanted guests. Nat Immunol 3: 1026-1032.
163. Zeaiter Z, Huynh HQ, Kanyo R, Stein M. 2008. CagA of Helicobacter pylori alters the expression and cellular distribution of host proteins involved in cell signaling. FEMS Microbiol Lett 288: 227-234.
164. Pflock M, Kennard S, Finsterer N, Beier D. 2006. Acid-responsive gene regulation in the human pathogen Helicobacter pylori. J Biotechnol 126: 52-60.